Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-043213)

Filing Details

Accession Number:: 0001209191-14-043213
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-06-24 08:20:55
Reporting Period:: 2014-06-23

Filing Date:: 2014-06-24
Accepted Time:: 2014-06-24 08:20:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1439222	Agios Pharmaceuticals Inc	AGIO	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1180432	John Maraganore	C/O Agios Pharmaceuticals, Inc. 38 Sidney Street, 2Nd Floor Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-06-23	2,300	$43.98	48,883	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The price reported is the weighted average of the shares acquired. The shares were acquired at varying prices in the range of $43.92 to $44.03. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares acquired at each separate price.